Get the Stockscreener App
30.28
0.62%
-0.1886
After Hours:
30.28
Putnam Biorevolution Etf stock is traded at $30.28, with a volume of 246.
It is down -0.62% in the last 24 hours and up +2.58% over the past month.
See More
Previous Close:
$30.47
Open:
$30.28
24h Volume:
246
Relative Volume:
1.26
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.58%
1M Performance:
+2.58%
6M Performance:
+6.45%
1Y Performance:
-5.94%
1-Day Range:
$30.28
$30.28
1-Week Range:
$29.90
$30.47
52-Week Range:
$24.57
$33.23
Putnam Biorevolution Etf Stock (SYNB) Company Profile
Name
Putnam Biorevolution Etf
Sector
Industry
Phone
-
Address
-
Compare SYNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYNB
Putnam Biorevolution Etf
|
30.28 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
324.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
657.41 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.72 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
586.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Putnam Biorevolution Etf Stock (SYNB) Latest News
Thermo Fisher Plunges 1.7%, Can the Bearish Momentum Be Stemmed? - AInvest
Trend Tracker for (SYNB) - news.stocktradersdaily.com
When the Price of (SYNB) Talks, People Listen - news.stocktradersdaily.com
Long Term Trading Analysis for (SYNB) - news.stocktradersdaily.com
(SYNB) Trading Signals - news.stocktradersdaily.com
(SYNB) Investment Analysis - Stock Traders Daily
Chemical Company DuPont Accelerates Electronics Business Separation, Retains Water Business - Benzinga
5 Best Biotech ETFs To Buy - Insider Monkey
Putnam Investments Launches Emerging Markets ex-China ETF - FinancialContent
Putnam Investments Launches Five New ESG-Focused ETFs - ESG News
Putnam Launches 2 Active ETFs Targeting BDCs and Biotechnology - ETF Trends
These long-duration bond ETFs have cratered the most from their peaks over past year, sinking below other assets as U.S. dollar soars - MarketWatch
Putnam Investments to Launch Two Innovative Active ETFs - Business Wire
‘Lots of stagflation in the new home market’: Homebuilder ETFs are struggling - MarketWatch
Putnam Biorevolution Etf Stock (SYNB) Financials Data
There is no financial data for Putnam Biorevolution Etf (SYNB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.61%
0.34%
Cap:
|
Volume (24h):